17033976|t|[Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine].
17033976|a|INTRODUCTION AND AIM: Dementia of Alzheimer type has become the most frequent type of dementia in our environment. Treatment persistence is a crucial factor to delay patient functional and cognitive impairment. The aim of the present study was to determine treatment persistence in usual care settings with four different antidementia drugs: donepezil, rivastigmine, galantamine and memantine in a cohort of patients with Alzheimer's dementia in Spain. PATIENTS AND METHODS: An Alzheimer type dementia retrospective cohort study was performed in 13 Primary Care Health Centers in Spain. The study included patients treated between January 2000 and March 2005. RESULTS: A total of 299 patients (44.8% female), mean age 77.9 years, were included: 101 donepezil (33.8.%), 105 rivastigmine (35.1%), 51 galantamine (17.1%) and 42 memantine (14.0%). Mean treatment duration was significantly different depending on therapy type, showing higher values for donepezil patients (mean: 83.3 weeks; 95% CI: 72.7-93.9) than for the other cholinesterase inhibitors: rivastigmine (mean: 76.6 weeks; 95% CI: 66.0-87.3), galantamine (mean: 65.8 weeks; 95% CI: 55.3-76.3) and memantine (60.9 weeks; 95% CI: 48.8-73.1), p = 0.049. Overall treatment persistence was significantly different between drugs, with again donepezil showing higher persistence (median time: 70.3 weeks; 95% CI: 49.8-90.7) than with the others drugs: rivastigmine (median time: 56.1 weeks; 95% CI: 36.1-76.2), galantamine (median time: 56.7 weeks; 95% CI: 41.1-72.3) and memantine (median time: 52.1 weeks; 95% CI: 35.2-69.1), log-rank = 10.16; p = 0.017. CONCLUSION: This study showed significative differences in the global treatment persistence among the considered drug-cholinesterase inhibitors, showing higher persistence resulting in patients treated with donepezil compared to those who received rivastigmine, galantamine or memantine.
17033976	95	114	Alzheimer's disease	Disease	MESH:D000544
17033976	115	123	patients	Species	9606
17033976	137	146	donepezil	Chemical	MESH:D000077265
17033976	148	160	rivastigmine	Chemical	MESH:D000068836
17033976	162	173	galantamine	Chemical	MESH:D005702
17033976	178	187	memantine	Chemical	MESH:D008559
17033976	212	220	Dementia	Disease	MESH:D003704
17033976	224	233	Alzheimer	Disease	MESH:D000544
17033976	276	284	dementia	Disease	MESH:D003704
17033976	356	363	patient	Species	9606
17033976	364	399	functional and cognitive impairment	Disease	MESH:D003072
17033976	532	541	donepezil	Chemical	MESH:D000077265
17033976	543	555	rivastigmine	Chemical	MESH:D000068836
17033976	557	568	galantamine	Chemical	MESH:D005702
17033976	573	582	memantine	Chemical	MESH:D008559
17033976	598	606	patients	Species	9606
17033976	612	632	Alzheimer's dementia	Disease	MESH:D000544
17033976	643	651	PATIENTS	Species	9606
17033976	668	677	Alzheimer	Disease	MESH:D000544
17033976	683	691	dementia	Disease	MESH:D003704
17033976	796	804	patients	Species	9606
17033976	874	882	patients	Species	9606
17033976	939	948	donepezil	Chemical	MESH:D000077265
17033976	963	975	rivastigmine	Chemical	MESH:D000068836
17033976	988	999	galantamine	Chemical	MESH:D005702
17033976	1015	1024	memantine	Chemical	MESH:D008559
17033976	1139	1148	donepezil	Chemical	MESH:D000077265
17033976	1149	1157	patients	Species	9606
17033976	1242	1254	rivastigmine	Chemical	MESH:D000068836
17033976	1294	1305	galantamine	Chemical	MESH:D005702
17033976	1348	1357	memantine	Chemical	MESH:D008559
17033976	1486	1495	donepezil	Chemical	MESH:D000077265
17033976	1596	1608	rivastigmine	Chemical	MESH:D000068836
17033976	1655	1666	galantamine	Chemical	MESH:D005702
17033976	1716	1725	memantine	Chemical	MESH:D008559
17033976	1986	1994	patients	Species	9606
17033976	2008	2017	donepezil	Chemical	MESH:D000077265
17033976	2049	2061	rivastigmine	Chemical	MESH:D000068836
17033976	2063	2074	galantamine	Chemical	MESH:D005702
17033976	2078	2087	memantine	Chemical	MESH:D008559
17033976	Comparison	MESH:D000068836	MESH:D000077265
17033976	Comparison	MESH:D000077265	MESH:D008559
17033976	Negative_Correlation	MESH:D000077265	MESH:D000544
17033976	Comparison	MESH:D005702	MESH:D008559
17033976	Negative_Correlation	MESH:D000068836	MESH:D000544
17033976	Comparison	MESH:D000068836	MESH:D005702
17033976	Negative_Correlation	MESH:D000077265	MESH:D003704
17033976	Negative_Correlation	MESH:D000068836	MESH:D003704
17033976	Negative_Correlation	MESH:D005702	MESH:D000544
17033976	Negative_Correlation	MESH:D008559	MESH:D000544
17033976	Negative_Correlation	MESH:D008559	MESH:D003704
17033976	Negative_Correlation	MESH:D005702	MESH:D003704
17033976	Comparison	MESH:D000077265	MESH:D005702

